Medscape
The European Medicines Agency (EMA) has recommended granting marketing authorization for orphan medicine Hetronifly (serplulimab, Henlius Europe) to treat extensive stage small cell lung cancer (ES-SCLC). The cancer is considered to be extensive if it has spread widely throughout the lung, to the other lung, or to other parts of the body…
Read More
Europe Recommends Lung Cancer Drug Hetronifly
Elida Schewe
06:37
The European Medicines Agency (EMA) has recommended granting marketing authorization for orphan medicine Hetronifly (serplulimab, Henlius Europe) to treat extensive stage small cell lung cancer (ES-SCLC). The cancer is considered to be extensive if it has spread widely throughout the lung, to the other lung, or to other parts of the body…
